Israeli Startups Look to New York, and increasingly Shanghai

Alan Patricof, a veteran venture capital investor and partner in NY based Greycroft Partners, said that “an Israeli company has to come to New York to access advertisers and content”, during the BootCamp Ventures Innovation Marathon in his recent visit to Israel.

Around the same time, a panel of investors (see coverage in Hebrew) met in the Peres Center for Peace and agreed that Israel must mature from its ‘startup’ state. Meir Brand, Google’s GM in Israel said Israel should start thinking more strategically about its future rather than just reacting to threats.

Chemi Peres, founding partner at Pitango and the head of the Israel-US chamber of commerce, said that the US is still a very important market for Israel. But, Peres says that China represents the next massive growth opportunity for Israeli companies. He added that while Pitango is looking at the next big thing for the fund in Education, Brain Research, Wireless Energy Transport and Nanotechnology (which he believes hasn’t reached a commercial state as of yet). Chemi firmly believes that Israel’s locked potential is embedded in the country’s ability to absorb the Israeli Arabs and Orthodox jews into the workforce, especially in the high-tech sector and predicts that it would have a similar effect to that of the Russian immigration in the early 1990s.

Eddy Shalev, founding partner of Genesis Partners was particularly bullish on Israel’s need to increase its commercial ties with China, Hong Kong and Singapore. He predicts that in the next five years the capital markets of those countries will become more central than those in New York.

All the above points of view emphasize how important it is for Israeli startups to establish their presence in foreign markets. But, with the rise in the importance of Asian markets, particularly the mammoth market of China, the question becomes: what ticket do startups need to buy first – New York or Shanghai?

Eze Vidra
Follow me

Eze Vidra

Chief Innovation Officer at Antidote
Eze is the Chief Innovation Officer at Antidote, a startup helping patients search and match to clinical trial, to accelerate medical breakthroughs. Previously, Ezewas a General Partner at Google Ventures Europe. Before GV, Eze founded and led Campus London, Google's first physical hub for startups, and was the Head Google for Entrepreneurs in Europe. He's an experienced product manager and startup mentor. In 2012 Eze founded Techbikers, a non-for profit supporting children education in developing countries.
Eze Vidra
Follow me

Latest posts by Eze Vidra (see all)

Eze Vidra

Eze is the Chief Innovation Officer at Antidote, a startup helping patients search and match to clinical trial, to accelerate medical breakthroughs. Previously, Eze was a General Partner at Google Ventures Europe. Before GV, Eze founded and led Campus London, Google’s first physical hub for startups, and was the Head Google for Entrepreneurs in Europe. He’s an experienced product manager and startup mentor. In 2012 Eze founded Techbikers, a non-for profit supporting children education in developing countries.